Patent ID: 7569567

Claim:
A method for the treatment of a pathology in which the peripheral benzodiazepine receptors are involved which comprises administering to a patient in need of said treatment a therapeutically effective amount of a compound of formula (I): wherein X represents a hydrogen or halogen atom, R 1 represents a hydrogen atom or a (C 1 -C 4 )alkyl group, R 2 and R 3 each represent, independently of one another, a hydrogen atom or a (C 1 -C 4 )alkyl group or else R 2 and R 3 form, with the nitrogen atom which carries them, a pyrrolidinyl, piperidinyl, morpholinyl or 4-alkylpiperazinyl group, and Het represents a heteroaryl group selected from pyridinyl, 1-oxidopyridinyl, quinolinyl, isoquinolinyl, pyrimidinyl, pyrazinyl and pyridazinyl, optionally substituted with one or more halogen atoms and/or one or more (C 1 -C 4 )alkyl or (C 1 -C 4 )alkoxy groups, or a hydrate or acid addition salt thereof; and wherein said pathology is selected from the group consisting of peripheral neuropathy, anxiety, epilepsy, acute or chronic renal insufficiency, glomerulonephritis, diabetic nephropathy, cardiac ischaemia and cardiac insufficiency, myocardial infarction, ischaemia of the lower limbs, coronary vasospasm, angina pectoris, graft rejection, and pulmonary inflammatory disease.